- Home
- MYNZ vs MEGL Comparison
MYNZ vs MEGL Comparison
Compare MYNZ & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYNZ | MEGL |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | Germany | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8M | 6.6M |
| IPO Year | 2021 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MYNZ | MEGL |
|---|---|---|
| Price | $1.16 | $1.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $14.00 | N/A |
| AVG Volume (30 Days) | ★ 928.5K | 17.7K |
| Earning Date | 12-29-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $659,935.00 | ★ $1,296,394.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.92 | $1.02 |
| 52 Week High | $8.20 | $5.52 |
Technical Indicators
Market Signals| Indicator | MYNZ | MEGL |
|---|---|---|
| Relative Strength Index (RSI) | 43.04 | 45.45 |
| Support Level | $1.00 | $1.22 |
| Resistance Level | $1.13 | $1.34 |
| Average True Range (ATR) | 0.18 | 0.07 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 20.51 | 50.00 |
Price Performance
Historical ComparisonAbout MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.